Abstract:Insulin is a protein hormone secreted by pancreatic,6 cells. One of its main functions is to keep the balance of glucose inside the body by regulating the absorption and metabolism of glucose in the periphery tissue, as well as the production and storage of hepatic glycogen. The insulin receptor is a transmembrane glycoprotein in which two a subunits with a molecular weight of 135 kD and two beta subunits with a molecular weight of 95 kD are joined by a disulfide bond to form a beta-alpha-alpha-beta structure. The extracellular a subunit, especially, its three domains near the N-terminal are partially responsible for signal transduction or ligand-binding, as indicated by the experiments. The extracellular a subunits are involved in binding the ligands. The experimental results indicate that the three domains of the N-terminal of the a subunits are the main determinative parts of the insulin receptor to bind the insulin or mimetic peptide. We employed the extracellular domain(PDBID: 11GR) of the insulin-like growth factor-1 receptor(IGF-1R) as the template to simulate and optimize the spatial structures of the three domains in the extracellular domain of the insulin receptor, which includes 468 residues. The work was accomplished by making use of the homology program in the Insight U package on an Origin3800 server. The docking calculations of the insulin receptor obtained by homology with hexapeptides were carried out by means of the program Affinity. The analysis indicated that there were hydrogen bonding, and electrostatic and hydrophobic effects in the docking complex of the insulin receptor with hexapeptides. Moreover, we described the spatial orientation of a mimetic peptide with agonist activity in the docking complex. We obtained a rough model of binding of DLAPSQ or STIVYS with the insulin receptor, which provides the powerful theoretical support for designing the minimal insulin mimetic peptide with agonist activity, making it possible to develop oral small molecular hypoglycemic drugs.

How Insulin Binds to the Insulin Receptor: A Synthetic Chemical Biology Approach

Decoding the cryptic active conformation of a protein by synthetic photoscanning: insulin inserts a detachable arm between receptor domains

How Insulin Binds: the B-Chain α-Helix Contacts the L1 β-Helix of the Insulin Receptor

How insulin binds: the B-chain alpha-helix contacts the L1 beta-helix of the insulin receptor.

Insulin and Its Single-Chain Analogue

Molecular Recognition of Insulin by a Synthetic Receptor

Diabetes-associated Mutations in Insulin: Consecutive Residues in the B Chain Contact Distinct Domains of the Insulin Receptor.

Enhancing the activity of insulin at the receptor interface: crystal structure and photo-cross-linking of A8 analogues.

Structural Resolution Of A Tandem Hormone-Binding Element In The Insulin Receptor And Its Implications For Design Of Peptide Agonists

Combinatorial libraries of bipodal binders of the insulin receptor

The A-chain of Insulin Contacts the Insert Domain of the Insulin Receptor

Binding Mode of Insulin Receptor and Agonist Peptide

Insertion of a synthetic switch into insulin provides metabolite-dependent regulation of hormone-receptor activation

Tuning Insulin Receptor Signaling Using De Novo Designed Agonists

Enhancing the Activity of a Protein by Stereospecific Unfolding: CONFORMATIONAL LIFE CYCLE OF INSULIN AND ITS EVOLUTIONARY ORIGINS

Structure-Based Computational Analysis of Interactions between Insulin Receptor and Insulin Inhibitory Receptor

Insulin-induced conformational changes in the full-length insulin receptor: structural insights gained from molecular modeling analyses

Diabetes-Associated Mutations in Human Insulin: Crystal Structure and Photo-Cross-Linking Studies of A-Chain Variant Insulin Wakayama

Insulin structure and function.

A λ-dynamics investigation of insulin and other A3 variant binding affinities to the insulin receptor

Chemical synthesis of peptides within the insulin superfamily